XEIA Venture Partners | News & content

The latest in Human 3

News, thoughts, podcasts and more from our portfolio companies and partners

What makes a Human 3 company?

The five qualities we look for

Lykos founder Rick Doblin on Joe Rogan

When will MDMA receive FDA approval?

The Human 3 thesis

In this foundational podcast, Sam and Brom discuss the origins of XEIA's Human 3 thesis

Superpower announces $30M Series A

XEIA portco raises to make concierge longevity medicine available to all

TARA Mind Founder Marcus Capone on Psychedelic Therapy: from SEALS to Startups

Will employers offer Ketamine therapy to their employees?

Psychedelics and AI in 2025 with Dillan DiNardo

A podcast with the founder of our portfolio company Mindstate Design Labs, Dillan DiNardo

NeuroBionics spins out of MIT and secures $3M pre-seed

NeuroBionics thinks deep brain stimulation should be less invasive - we agree

AI designed mRNA therapies: a Universal Toolkit for Genetic Medicine

How Kerna is building foundation AI models to unlock the full potential of mRNA

Kerna Labs raises Seed from Susa & Google's AI fund

Moderna's former CSO has a new startup using AI to improve mRNA therapies

Bloomberg's Emily Chang interviews Motif Neurotech

In new Bloomberg series "Posthuman"

Making Deep Brain Stimulation Minimally Invasive

A podcast with MJ Antonini and Nicki Driscoll of NeuroBionics

TippingPoint's IndieBio demo day presentation

Laura explains how and why TippingPoint is drugging aberrant chromatin

AI to uncover nature's hidden cures - Lars Wilde of Pangea

The history, motivation and rationale behind using nature as inspiration for drug development

Advancements in Male Sexual Health

A podcast with John Boghossian & Ryan Protzko of Kadence Bio

Y Combinator's Garry Tan on Mindstate & Psychedelics

Y Combinator and Garry Tan's Initialized Capital are both investors in Mindstate

Vonova's presentation at LSI 2024

Watch Vonova CEO Wes Jones showcase their transvascular BCI platform

Motif raises $19M Series A led by Arboretum Ventures

Proceeds will advance Motif's brain-computer interface for Treatment-Resistant Depression

Ending the Opiate epidemic with Ibogaine therapy

How Beond's Cancun based clinic is changing lives with Ibogaine

Freedom Bio cofounder on the Tim Ferriss Show

Dr John Krystal takes a comprehensive deep dive into all things Ketamine

The art and science of drug design

A podcast with Sam Banister, PhD - cofounder and CSO of Xylo

Want more from XEIA?

Stay up to date on Human 3 - the new epoch of health, wellbeing and performance

Thank you! You've been added to our mailing list.

Oops! Something went wrong while submitting the form.

Human 3 manifesto News & content Portfolio Podcast Jobs

X-disciplinary Exploration, Investment & Acceleration
‍
© 2025 XEIA Venture Partners, LLC